{"gene":"IER3","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1998,"finding":"IEX-1 (IER3) is transcriptionally induced by TNF in an NF-κB-dependent manner and protects cells from Fas- or TNF-induced apoptosis; overexpression of antisense IEX-1 sensitized cells to TNF-induced killing, establishing IEX-1 as a downstream NF-κB target mediating cell survival.","method":"Antisense overexpression, transfection of IEX-1 expression vector, cell viability assays in TNF/Fas-stimulated cells","journal":"Science","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function (antisense) and gain-of-function with defined apoptosis phenotype, single lab","pmids":["9703517"],"is_preprint":false},{"year":1998,"finding":"The IEX-1 (p22/PRG1) promoter contains functional binding sites for p53 and NF-κB; gel shift/supershift assays confirmed direct binding of both transcription factors, and reporter assays demonstrated p53-dependent and TNF/NF-κB-dependent transactivation of the IEX-1 promoter.","method":"EMSA/supershift assay, CAT reporter gene assay, stable transfection with temperature-sensitive p53","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — direct DNA binding demonstrated by EMSA and functional promoter assays, replicated across multiple groups","pmids":["9781666","9627114","11844788","12360408"],"is_preprint":false},{"year":2002,"finding":"IEX-1 is a direct substrate of ERK2; it is phosphorylated in vivo upon ERK activation, interacts specifically with phosphorylated ERKs (but not JNK or p38), and upon ERK-mediated phosphorylation acquires anti-apoptotic activity. Independently, IEX-1 potentiates ERK activation, with ERK-docking-site mutants abolishing this potentiation while phosphorylation-site mutants abolish survival signaling.","method":"Phosphorylation screening with active ERK2, in vivo phosphorylation assay, IEX-1 domain mutants (ERK phosphoacceptor and docking site mutations), cell death assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay plus in vivo phosphorylation plus structure-function mutagenesis in a single study","pmids":["12356731"],"is_preprint":false},{"year":2006,"finding":"B56-containing PP2A holoenzymes dephosphorylate ERK; IEX-1 binds directly to B56 subunits and to phosphorylated ERK, enabling ERK to transphosphorylate B56 at a conserved Ser/Pro site, which triggers dissociation of B56 from the PP2A catalytic subunit, thereby inhibiting ERK dephosphorylation and sustaining ERK activity.","method":"RNAi of B56 subunits, overexpression, co-immunoprecipitation, in vitro phosphatase assay, ERK phosphorylation assays, domain mutants","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — reconstituted PP2A inhibition in vitro, reciprocal co-IP, mutagenesis, multiple orthogonal methods in one study","pmids":["16456541"],"is_preprint":false},{"year":2007,"finding":"IEX-1 inhibits B56-PP2A-mediated dephosphorylation of Akt on both Thr308 and Ser473, thereby sustaining Akt activity in an ERK-dependent manner; an IEX-1 mutant deficient in ERK binding had no effect on Akt, and B56β/γ mutants that cannot be phosphorylated by the ERK·IEX-1 complex showed enhanced ability to dephosphorylate Akt.","method":"Overexpression and RNAi of IEX-1 and B56 subunits, ERK dominant-negative mutants, phospho-Akt immunoblot, ERK-binding-deficient IEX-1 mutant","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches including dominant-negatives and structure-function mutants, mechanistically extending EMBO J 2006 findings","pmids":["17200115"],"is_preprint":false},{"year":2001,"finding":"IEX-1 overexpression in HeLa cells accelerates cell cycle progression and increases susceptibility to apoptosis induced by death-receptor ligands or etoposide; NF-κB-dependent induction of IEX-1 does not mediate NF-κB's anti-apoptotic effect but instead modulates cell cycle.","method":"Inducible IEX-1 expression vector, antisense hammerhead ribozyme knockdown, apoptosis and cell cycle assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal gain-of-function and loss-of-function with defined apoptosis phenotype, single lab","pmids":["11244505"],"is_preprint":false},{"year":2002,"finding":"Transgenic expression of IEX-1 specifically in T cells impairs Fas- and TCR/CD3-induced apoptosis, extends the effector phase of immune responses, and leads to lupus-like autoimmunity and T-cell lymphomas in aging mice, demonstrating a T-cell-specific anti-apoptotic role in vivo.","method":"Eμ-IEX-1 transgenic mice, T cell apoptosis assays (Fas/TCR ligation), immune response phenotyping, lymphoma analysis","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — in vivo transgenic model with defined molecular mechanism, replicated in separate transgenic study","pmids":["11782530","14534530"],"is_preprint":false},{"year":2003,"finding":"IEX-1 attenuation of NF-κB activation involves inhibition of the 26S proteasome and altered IκBα turnover; IEX-1 overexpression decreases nuclear p65 accumulation and NF-κB reporter activity, while IEX-1 disruption by ribozymes increases NF-κB activity and decreases apoptotic sensitivity.","method":"Stable inducible IEX-1 overexpression, anti-IEX-1 hammerhead ribozyme knockdown, gel-shift and luciferase reporter assays, fluorometric proteasome assay, immunofluorescence for nuclear p65","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal gain/loss-of-function with multiple mechanistic readouts, single lab","pmids":["12761504"],"is_preprint":false},{"year":2007,"finding":"IEX-1 directly binds the C-terminal transactivation domain of RelA/p65 (shown by GST pulldown and confirmed by endogenous co-immunoprecipitation), inhibits RelA/p65-dependent transactivation, reduces expression of anti-apoptotic NF-κB targets (Bcl-2, Bcl-xL, cIAP1, cIAP2), and associates with their promoters (ChIP assay).","method":"GST pulldown, co-immunoprecipitation, GAL4/luciferase reporter assay, chromatin immunoprecipitation (ChIP), deletion constructs of IEX-1","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1-2 — direct protein interaction verified by GST-pulldown and reciprocal co-IP, functional consequence demonstrated by reporter and ChIP assays","pmids":["18191642"],"is_preprint":false},{"year":2008,"finding":"IEX-1 targets the mitochondrial F1Fo-ATPase inhibitor (IF1) for degradation via interaction with the C-terminus of IF1, leading to acceleration of ATP hydrolysis, reduction of mitochondrial ROS production, and a metabolic shift from oxidative phosphorylation to glycolysis; IEX-1 knockout mice show stabilized IF1 and reduced mitochondrial ATPase activity in vivo.","method":"Co-immunoprecipitation, C-terminal truncation studies, siRNA knockdown of IF1, IEX-1 knockout mice, ATP hydrolysis assay, ROS measurement, metabolic assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1-2 — direct interaction mapped to specific domain, siRNA phenocopy, in vivo knockout validation with biochemical readout","pmids":["19096392"],"is_preprint":false},{"year":2005,"finding":"IEX-1 localizes to distinct subnuclear structures in a nuclear-localization-sequence-dependent manner, partially co-localizes with PML nuclear bodies, physically interacts with PML (shown by co-immunoprecipitation), and is subject to nucleocytoplasmic shuttling via CRM1; loss of the NLS impairs pro-apoptotic but not anti-apoptotic function.","method":"Confocal microscopy of GFP-IEX-1 fusion protein, double immunofluorescence, leptomycin B treatment, co-immunoprecipitation with PML isoforms, NLS deletion mutant apoptosis assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal localization methods plus functional mutagenesis and direct interaction by co-IP","pmids":["15855159"],"is_preprint":false},{"year":2006,"finding":"IEX-1 anti- and pro-apoptotic activities map to distinct protein domains: a transmembrane-like hydrophobic region is critical for both functions; N-linked glycosylation sites, phosphorylation sites, and the C-terminus are required for anti-apoptotic but not pro-apoptotic activity; the nuclear localization sequence is required for pro-apoptotic but not anti-apoptotic activity; anti-apoptotic mutants all fail to suppress acute mitochondrial ROS production.","method":"Site-directed mutagenesis of hydrophobic residues, glycosylation/phosphorylation sites, NLS; apoptosis assays; intracellular ROS measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic structure-function mutagenesis with multiple functional readouts in a single study","pmids":["16567805"],"is_preprint":false},{"year":2009,"finding":"IEX-1 interacts with the anti-apoptotic protein MCL-1 (identified by yeast two-hybrid and confirmed by endogenous co-immunoprecipitation); IEX-1-induced caspase-dependent apoptosis requires BIM but not NOXA or PUMA, and is modulated by MCL-1 expression levels.","method":"Yeast two-hybrid screen, co-immunoprecipitation in human cells, BIM/NOXA/PUMA knockout cells, caspase assay, mitochondrial membrane potential assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — interaction confirmed by endogenous co-IP and mechanistically linked to BIM-dependent apoptosis via genetic knockouts","pmids":["19285955"],"is_preprint":false},{"year":2010,"finding":"IEX-1 (IER3) interacts with MCL-1 and is required for ATM-dependent nuclear translocation of MCL-1 in response to DNA damage; IEX-1 is rapidly induced by γ-irradiation in an ATM-dependent manner; loss of IEX-1 prevents Mcl-1 nuclear accumulation, impairs Chk1 activation and G2 checkpoint arrest, and leads to genomic instability; proteasomal degradation of IEX-1 reverses Mcl-1 to the cytosol.","method":"IEX-1 knockdown/knockout, ATM inhibition, γ-irradiation, nuclear fractionation, co-immunoprecipitation, Chk1 phosphorylation assay, genomic instability assay","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, genetic and pharmacological manipulation, clearly defined molecular pathway","pmids":["20467439"],"is_preprint":false},{"year":2013,"finding":"TPO specifically activates ERK and NF-κB pathways in hematopoietic stem and progenitor cells; both pathways cooperate to induce IEX-1 upon DNA damage; IEX-1 forms a complex with phospho-ERK and the catalytic subunit of DNA-PK, which is necessary and sufficient for TPO-increased DNA-PK activation and NHEJ repair in mouse and human HSPCs.","method":"Signaling pathway inhibitors, IEX-1 knockdown and overexpression, co-immunoprecipitation of IEX-1/pERK/DNA-PKcs complex, NHEJ repair assay, DNA-PK phosphorylation assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — ternary complex identified by co-IP, loss- and gain-of-function with defined biochemical phenotype, validated in both mouse and human cells","pmids":["24184684"],"is_preprint":false},{"year":2012,"finding":"IEX-1 deficiency promotes Th17 differentiation and impairs Th1 cell survival through increased mitochondrial ROS production following T cell activation; mitochondrial ROS augment B cell-activating transcription factor expression contributing to IL-17 production; ROS scavengers or mitochondria-specific antioxidants inhibit Th17 induction in IEX-1 KO mice.","method":"IEX-1 knockout mice, collagen-induced arthritis model, mitochondrial ROS measurement, N-acetylcysteine/mitoquinone treatment, flow cytometry for Th17/Th1, IL-17 ELISA","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with mechanistically defined pathway, pharmacological rescue experiments, multiple orthogonal readouts","pmids":["22798682"],"is_preprint":false},{"year":2013,"finding":"IEX-1 modulates Nrf2 activity through the PI3K/Akt-Fyn pathway in colonic epithelial cells; IER3 deficiency (KO mice or shRNA knockdown) increases Nrf2 nuclear accumulation and target gene expression; IER3 deficiency reduces ROS and decreases apoptotic sensitivity; PI3K inhibition or Akt/Fyn knockdown abrogates IER3-deficiency-induced Nrf2 activation.","method":"Ier3 knockout mice, shRNA knockdown, IER3 overexpression, Nrf2 nuclear fractionation, Nrf2 target gene qPCR, PI3K inhibitor, siRNA knockdown of Akt and Fyn, ROS measurement, clonogenicity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — in vivo KO combined with in vitro mechanistic dissection using pathway inhibitors and multiple knockdowns","pmids":["24311782"],"is_preprint":false},{"year":2014,"finding":"IER3 sustains ERK1/2 phosphorylation in pancreatic cancer cells by inhibiting PP2A phosphatase activity; IER3 expression is required for KrasG12D-driven PanIN and PDAC development in vivo, and IER3-deficient KrasG12D mice show delayed PanIN and PDAC formation.","method":"IER3 overexpression and knockdown in human pancreatic cancer cells, PP2A phosphatase activity assay, IER3/KrasG12D double mutant mice, immunohistochemistry for pERK1/2 and IER3","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — in vitro phosphatase assay plus in vivo genetic model with defined oncogenic pathway","pmids":["25250570"],"is_preprint":false},{"year":2016,"finding":"MDM2 is the E3 ubiquitin ligase responsible for IER3 ubiquitination and proteasomal degradation; polyubiquitination at lysine 60 of IER3 is essential; FHL2 acts as a scaffold protein that binds both IER3 and MDM2, facilitating efficient MDM2-mediated IER3 degradation.","method":"Co-immunoprecipitation of MDM2-IER3-FHL2 ternary complex, ubiquitination assay, K60 point mutant of IER3, FHL2/MDM2 siRNA knockdown, proteasome inhibitor, cell cycle assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — direct ubiquitination assay with specific residue identified, ternary complex defined by co-IP, mechanistic rescue experiments","pmids":["26973248"],"is_preprint":false},{"year":2003,"finding":"In vascular smooth muscle cells, IEX-1 expression induced by NF-κB (abolished by IκBα overexpression) inhibits cell cycle progression by reducing p27kip1 degradation and Rb hyperphosphorylation; adenoviral IEX-1 overexpression in vivo reduces neointima formation after carotid artery injury.","method":"Northern and Western blot, adenoviral gene transfer, 3H-thymidine incorporation, p27kip1 immunoblot, Rb phosphorylation assay, in vivo carotid injury model, histomorphometry","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — in vitro mechanistic pathway with cell cycle targets plus in vivo validation, NF-κB pathway placed by IκBα overexpression","pmids":["14592999"],"is_preprint":false},{"year":2002,"finding":"In cardiomyocytes, IEX-1 is induced by biomechanical strain in an NF-κB-dependent manner (abolished by IκBα overexpression), and adenoviral overexpression of IEX-1 abolishes cardiomyocyte hypertrophy induced by mechanical strain, phenylephrine, or endothelin-1 without affecting cell viability.","method":"In vivo pressure overload model, in vitro mechanical stimulation, adenoviral IEX-1 overexpression, IκBα overexpression, Northern/Western blot, hypertrophy readouts","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo and in vitro model with NF-κB pathway placement and gain-of-function phenotype, single lab","pmids":["11934837"],"is_preprint":false},{"year":2006,"finding":"HSV-1 ICP27 stabilizes ARE-containing IEX-1 mRNA by activating the p38/MK2 MAPK pathway; ICP27 mutants deficient in p38 activation fail to stabilize IEX-1 mRNA, and the p38 inhibitor SB203580 abrogates IEX-1 mRNA stabilization, whereas the virion host shutoff protein (vhs) plays little role.","method":"Panel of ICP27 mutant HSV-1 isolates, actinomycin D mRNA stability assay, p38 inhibitor SB203580, Northern blot/real-time PCR","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic panel of mutants with pharmacological rescue defines ICP27/p38 as stabilization mechanism","pmids":["16973576"],"is_preprint":false},{"year":2015,"finding":"TAp73β transcriptionally activates IER3 in cervical cancer cells (whereas p53 and TAp63 do not); IER3 silencing suppresses TAp73β-induced apoptosis but not p53-induced apoptosis; etoposide upregulates TAp73β and IER3 through c-Abl kinase, and etoposide chemosensitivity is largely determined by the TAp73β-IER3 axis.","method":"Luciferase reporter assay, IER3 siRNA knockdown, p53/TAp63/TAp73β expression vectors, c-Abl inhibition, apoptosis assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — transcriptional specificity established by reporter assay, siRNA epistasis places IER3 downstream of c-Abl/TAp73β","pmids":["25666857"],"is_preprint":false},{"year":2016,"finding":"IEX-1 deficiency induces browning of white adipose tissue and promotes alternative activation of adipose macrophages, leading to increased thermogenic gene expression (e.g., UCP1), enhanced thermogenesis, and resistance to high-fat diet-induced obesity; IEX-1 is a negative regulator of WAT browning.","method":"IEX-1 knockout mice, high-fat diet feeding, gene expression profiling of thermogenic genes, energy expenditure measurement, macrophage polarization assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with mechanistic pathway (macrophage polarization driving browning), but detailed molecular mechanism of IEX-1 action not fully resolved","pmids":["27063893"],"is_preprint":false},{"year":2016,"finding":"MCPIP1 RNase interacts with IER3 mRNA via a stem-loop structure in the IER3 3'UTR and degrades it; deletion of the stem-loop abolishes MCPIP1-mediated destabilization; IF-combined smRNA FISH confirms co-localization of MCPIP1 protein with IER3 mRNA in cells; RNA immunoprecipitation confirms MCPIP1-IER3 mRNA interaction in vivo.","method":"Dual luciferase assay with IER3 3'UTR constructs, deletion mutagenesis of stem-loop, immunofluorescence-combined single-molecule RNA FISH, RNA immunoprecipitation","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 — direct RNA-protein interaction confirmed by RIP and smRNA FISH, deletion mutant identifies functional element","pmids":["27256408"],"is_preprint":false},{"year":2014,"finding":"IL-1β-induced IER3 expression is mediated through ERK1/2 and transcription factor Elk-1; Elk-1 is phosphorylated by ERK and binds ETS5/6 sequences in the IER3 promoter; mutation of ETS5/6 abolishes IL-1β-induced and constitutively active Elk-1-driven IER3 promoter activity.","method":"Promoter-luciferase reporter assay, EMSA, site-directed mutagenesis of ETS binding sites, constitutively active Elk-1 (Elk-VP16), Elk-1 phosphorylation immunoblot","journal":"Cytokine","confidence":"Medium","confidence_rationale":"Tier 2 — EMSA and mutagenesis define promoter element; gain-of-function with constitutively active Elk-1 confirms mechanism","pmids":["25066273"],"is_preprint":false},{"year":2008,"finding":"IEX-1 overexpression in HeLa cells induces astrocytic differentiation phenotype in U87-MG glioma cells (increased S-100 and GFAP); IEX-1 acts downstream of PKA in cAMP-induced astrocytic differentiation, as antisense IEX-1 abolishes dbcAMP-induced morphological changes, while IEX-1-induced differentiation is not blocked by PKA inhibitor H89.","method":"IEX-1 transfection, antisense RNA disruption, dbcAMP stimulation, PKA inhibitor H89, GFAP/S-100 immunoblot, morphological analysis","journal":"Journal of cellular biochemistry","confidence":"Low","confidence_rationale":"Tier 3 — single lab, single antisense approach with limited mechanistic resolution of pathway position","pmids":["16960879"],"is_preprint":false},{"year":2016,"finding":"EGR2 is a transcription factor downstream of gonadotropins that directly transactivates IER3 in granulosa cells; EGR2 binds EGR-binding elements in the IER3 promoter (confirmed by EMSA, ChIP, luciferase assay); EGR2-promoted cell survival requires IER3 as a mediator, and EGR2 also regulates MCL-1 expression.","method":"Luciferase reporter assay, EMSA, ChIP, EGR2 overexpression and knockdown, IER3 knockdown, cell survival assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods confirming transcriptional regulation; epistasis established by IER3 knockdown reversing EGR2 survival effect","pmids":["27890615"],"is_preprint":false},{"year":2021,"finding":"TRAIL physically interacts with IER3 (shown by co-immunoprecipitation and immunofluorescence co-localization) in hepatocellular carcinoma cells; TRAIL and IER3 cooperate to inhibit Wnt/β-catenin signaling, thereby inducing apoptosis and reducing proliferation and migration both in vitro and in vivo.","method":"Co-immunoprecipitation, immunofluorescence, Wnt/β-catenin pathway reporter/immunoblot, apoptosis/proliferation/migration assays, xenograft model","journal":"Cancer cell international","confidence":"Low","confidence_rationale":"Tier 3 — single co-IP and co-localization without detailed mechanistic dissection of the direct interaction","pmids":["33472635"],"is_preprint":false}],"current_model":"IER3 is a stress-inducible, NF-κB/p53/ERK-regulated immediate-early gene whose protein acts as a dual-function regulator of cell survival: it binds and inhibits B56-containing PP2A holoenzymes (by enabling ERK-mediated phosphorylation of B56 subunits), thereby sustaining both ERK and Akt phosphorylation; directly interacts with RelA/p65 to attenuate NF-κB transactivation; targets the mitochondrial ATPase inhibitor IF1 for degradation to suppress ROS production; interacts with MCL-1 to control its ATM-dependent nuclear translocation and DNA damage checkpoint function; forms a complex with pERK and DNA-PKcs to promote NHEJ repair; and undergoes MDM2-FHL2-mediated ubiquitination at K60 for proteasomal degradation, with its nucleocytoplasmic distribution and functional output (pro- or anti-apoptotic) determined by distinct structural domains including a transmembrane-like hydrophobic region, glycosylation/phosphorylation sites, and a nuclear localization sequence."},"narrative":{"teleology":[{"year":1998,"claim":"IER3 was established as an NF-κB- and p53-responsive immediate-early gene with anti-apoptotic function, answering whether NF-κB transcriptional targets directly mediate cell survival after TNF/Fas signaling.","evidence":"Antisense knockdown sensitized cells to TNF-induced killing; EMSA and reporter assays confirmed direct p53 and NF-κB binding to the IER3 promoter in multiple cell lines","pmids":["9703517","9781666","9627114"],"confidence":"High","gaps":["Downstream effector mechanism of IER3-mediated survival was unknown","Relative contributions of p53 vs NF-κB to physiological IER3 induction were not delineated"]},{"year":2002,"claim":"IER3 was identified as a direct ERK2 substrate whose phosphorylation is required for anti-apoptotic activity, and reciprocally, IER3 potentiates ERK activation — establishing a positive feedback loop between IER3 and MAPK signaling.","evidence":"In vitro kinase assay with ERK2, in vivo phosphorylation, ERK-docking-site and phosphoacceptor mutants with cell death assays","pmids":["12356731"],"confidence":"High","gaps":["The direct molecular target through which IER3 potentiates ERK was not identified","Whether ERK phosphorylation of IER3 controls its stability or localization was unknown"]},{"year":2002,"claim":"Transgenic mouse models demonstrated that IER3 overexpression in T cells impairs Fas- and TCR-induced apoptosis in vivo, leading to autoimmunity and lymphomagenesis — establishing IER3's in vivo relevance to immune homeostasis.","evidence":"Eμ-IER3 transgenic mice with T cell apoptosis assays, immune response phenotyping, and lymphoma analysis","pmids":["11782530","14534530"],"confidence":"High","gaps":["Molecular target in the Fas/TCR death pathway inhibited by IER3 was not identified","Whether IER3 effects were cell-autonomous in vivo was not fully resolved"]},{"year":2005,"claim":"IER3 was shown to undergo nucleocytoplasmic shuttling and to co-localize with PML nuclear bodies, with its NLS required selectively for pro-apoptotic function — resolving how a single protein can exert opposing effects on cell fate depending on subcellular compartment.","evidence":"GFP-IER3 confocal microscopy, leptomycin B treatment, co-IP with PML, NLS deletion mutant apoptosis assays","pmids":["15855159"],"confidence":"High","gaps":["The nuclear target(s) mediating IER3's pro-apoptotic function were not identified","Functional significance of PML body association was not mechanistically dissected"]},{"year":2006,"claim":"The mechanism of ERK potentiation was solved: IER3 inhibits B56-containing PP2A holoenzymes by bridging phospho-ERK to B56 subunits, enabling ERK-mediated transphosphorylation and dissociation of B56 from the PP2A catalytic subunit — identifying IER3 as a PP2A inhibitor.","evidence":"Reciprocal co-IP, in vitro phosphatase assay reconstitution, RNAi of B56 subunits, domain mutagenesis","pmids":["16456541"],"confidence":"High","gaps":["Whether IER3 inhibits PP2A complexes containing other B-family subunits was not tested","Structural basis of the IER3–B56 interaction was unknown"]},{"year":2006,"claim":"Systematic structure-function analysis mapped anti-apoptotic activity to glycosylation/phosphorylation sites and the C-terminus, and pro-apoptotic activity to the NLS, with both requiring a transmembrane-like hydrophobic region — establishing that dual functionality is encoded in separable protein domains.","evidence":"Site-directed mutagenesis of hydrophobic residues, glycosylation sites, phosphorylation sites, NLS; apoptosis and ROS assays","pmids":["16567805"],"confidence":"High","gaps":["Whether post-translational modifications control domain switching in physiological settings was not shown","The transmembrane-like region's membrane insertion and topology were not resolved structurally"]},{"year":2007,"claim":"IER3-mediated PP2A inhibition was extended to the Akt pathway: IER3 sustains Akt phosphorylation at Thr308 and Ser473 via B56-PP2A inhibition in an ERK-dependent manner, linking IER3 to two major survival kinase cascades simultaneously.","evidence":"Overexpression and RNAi of IER3 and B56 subunits, ERK dominant-negative mutants, phospho-Akt immunoblot, ERK-binding-deficient IER3 mutant","pmids":["17200115"],"confidence":"High","gaps":["Whether Akt sustaining is the primary mechanism of IER3's anti-apoptotic activity versus other targets was not determined"]},{"year":2007,"claim":"The negative-feedback role of IER3 on NF-κB was mechanistically defined: IER3 directly binds the RelA/p65 transactivation domain, represses NF-κB target genes (Bcl-2, Bcl-xL, cIAP1/2), and associates with their promoters — explaining how an NF-κB-induced gene can attenuate its own inducer.","evidence":"GST pulldown, endogenous co-IP, GAL4/luciferase reporter, ChIP on anti-apoptotic gene promoters","pmids":["18191642"],"confidence":"High","gaps":["Whether IER3–p65 interaction competes with coactivators or recruits corepressors was not resolved","Chromatin-level mechanism of repression was not defined"]},{"year":2008,"claim":"IER3 was found to target the mitochondrial F1Fo-ATPase inhibitor IF1 for degradation, accelerating ATP hydrolysis and reducing mitochondrial ROS — providing a direct metabolic mechanism for IER3's effects on ROS and explaining the ROS phenotype of IER3-knockout mice.","evidence":"Co-IP mapping to IF1 C-terminus, IF1 siRNA phenocopy, IER3 KO mice with stabilized IF1, ATP hydrolysis and ROS assays","pmids":["19096392"],"confidence":"High","gaps":["The degradation pathway (proteasomal vs lysosomal) through which IER3 eliminates IF1 was not defined","Whether IF1 degradation fully accounts for IER3's metabolic effects was untested"]},{"year":2010,"claim":"IER3 was shown to interact with MCL-1 and to be required for ATM-dependent nuclear translocation of MCL-1 after DNA damage, linking IER3 to the DNA damage checkpoint: loss of IER3 prevents MCL-1 nuclear accumulation, impairs Chk1 activation and G2 arrest, and causes genomic instability.","evidence":"IER3 knockdown/knockout, ATM inhibition, γ-irradiation, nuclear fractionation, Chk1 phosphorylation assay","pmids":["20467439"],"confidence":"High","gaps":["How IER3 mediates MCL-1 nuclear import (carrier vs retention mechanism) was not determined","Whether IER3–MCL-1 interaction is direct or requires additional factors in vivo was uncertain"]},{"year":2012,"claim":"IER3 deficiency was shown to promote Th17 differentiation at the expense of Th1 survival through increased mitochondrial ROS, establishing IER3 as a metabolic regulator of T helper cell fate decisions.","evidence":"IER3 KO mice in collagen-induced arthritis model, mitochondrial ROS measurement, antioxidant rescue of Th17 skewing","pmids":["22798682"],"confidence":"High","gaps":["Whether ROS-mediated Th17 skewing is solely via BATF or involves additional transcription factors was not fully resolved","Cell-intrinsic vs cell-extrinsic contributions in vivo were not separated"]},{"year":2013,"claim":"IER3 was identified as a scaffold for a phospho-ERK/DNA-PKcs complex that promotes NHEJ repair in hematopoietic stem cells downstream of TPO, establishing a direct role in DNA repair beyond checkpoint activation.","evidence":"Co-IP of ternary IER3/pERK/DNA-PKcs complex, IER3 knockdown and overexpression, NHEJ repair assay in mouse and human HSPCs","pmids":["24184684"],"confidence":"High","gaps":["Whether IER3 activates DNA-PKcs kinase activity directly or facilitates its recruitment to DSBs was not resolved","Contribution of IER3-dependent NHEJ to HSC genomic integrity during aging was not tested"]},{"year":2014,"claim":"IER3 was shown to be essential for KrasG12D-driven pancreatic tumorigenesis through PP2A-dependent ERK sustaining, as IER3-deficient mice exhibited delayed PanIN and PDAC formation — providing in vivo genetic evidence that IER3's PP2A-inhibitory function is oncogenically required.","evidence":"IER3/KrasG12D compound mutant mice, PP2A phosphatase assay, pERK immunohistochemistry","pmids":["25250570"],"confidence":"High","gaps":["Whether therapeutic PP2A reactivation can substitute for IER3 loss in established tumors was not tested","Contribution of IER3's non-PP2A functions to pancreatic tumorigenesis was not assessed"]},{"year":2016,"claim":"MDM2 was identified as the E3 ubiquitin ligase for IER3, with FHL2 acting as a scaffold and K60 as the critical ubiquitination site — defining the proteolytic control mechanism for IER3 protein levels.","evidence":"Ubiquitination assay, K60 point mutant, co-IP of MDM2–FHL2–IER3 ternary complex, FHL2/MDM2 siRNA","pmids":["26973248"],"confidence":"High","gaps":["Whether other E3 ligases contribute to IER3 turnover in specific contexts was not examined","How IER3 ubiquitination is regulated by upstream signals beyond MDM2/FHL2 was not defined"]},{"year":null,"claim":"The structural basis of IER3's interactions with its multiple partners (B56, ERK, RelA, IF1, MCL-1, DNA-PKcs) remains undetermined, as does how IER3 integrates competing pro-survival and pro-apoptotic outputs in a single cell under physiological conditions.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of IER3 or any IER3-containing complex exists","How post-translational modifications dynamically partition IER3 among its functional complexes is unknown","Whether IER3's transmembrane-like domain inserts into membranes or serves as a protein-protein interaction surface is unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,4,7,8,17]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[3,4,14,18]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10,11,13]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[9,11]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[10,11]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3,4,7,8,17]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,5,6,11,12]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[13,14]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6,15]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[18]}],"complexes":["IER3–pERK–B56-PP2A","IER3–pERK–DNA-PKcs","IER3–MDM2–FHL2"],"partners":["PPP2R5A","PPP2R5B","PPP2R5C","MAPK1","RELA","MCL1","PRKDC","MDM2"],"other_free_text":[]},"mechanistic_narrative":"IER3 is a stress-inducible immediate-early gene that functions as a context-dependent regulator of cell survival, apoptosis, and DNA damage responses by modulating multiple signaling cascades. Its principal biochemical activity is inhibition of B56-containing PP2A holoenzymes: IER3 binds B56 subunits and phosphorylated ERK, enabling ERK-mediated transphosphorylation of B56 that dissociates B56 from PP2A catalytic subunits, thereby sustaining both ERK and Akt phosphorylation [PMID:16456541, PMID:17200115, PMID:25250570]. IER3 also directly binds RelA/p65 to attenuate NF-κB transactivation of anti-apoptotic targets [PMID:18191642], targets the mitochondrial ATPase inhibitor IF1 for degradation to suppress ROS production [PMID:19096392], and forms a complex with phospho-ERK and DNA-PKcs to promote NHEJ repair in hematopoietic stem cells [PMID:24184684]. IER3 protein stability is controlled by MDM2-mediated ubiquitination at K60, scaffolded by FHL2, and its pro- versus anti-apoptotic output is determined by distinct structural domains including a nuclear localization sequence required for pro-apoptotic function and glycosylation/phosphorylation sites required for anti-apoptotic function [PMID:26973248, PMID:16567805]."},"prefetch_data":{"uniprot":{"accession":"P46695","full_name":"Radiation-inducible immediate-early gene IEX-1","aliases":["Differentiation-dependent gene 2 protein","Protein DIF-2","Immediate early protein GLY96","Immediate early response 3 protein","PACAP-responsive gene 1 protein","Protein PRG1"],"length_aa":156,"mass_kda":16.9,"function":"May play a role in the ERK signaling pathway by inhibiting the dephosphorylation of ERK by phosphatase PP2A-PPP2R5C holoenzyme. Also acts as an ERK downstream effector mediating survival. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/P46695/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/IER3","classification":"Not Classified","n_dependent_lines":62,"n_total_lines":1208,"dependency_fraction":0.05132450331125828},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/IER3","total_profiled":1310},"omim":[{"mim_id":"614812","title":"NUCLEAR PROTEIN, TRANSCRIPTIONAL REGULATOR, 1; NUPR1","url":"https://www.omim.org/entry/614812"},{"mim_id":"614660","title":"PAT1 HOMOLOG 1, PROCESSING BODY mRNA DECAY FACTOR; PATL1","url":"https://www.omim.org/entry/614660"},{"mim_id":"603075","title":"MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1","url":"https://www.omim.org/entry/603075"},{"mim_id":"602996","title":"IMMEDIATE-EARLY RESPONSE 3; IER3","url":"https://www.omim.org/entry/602996"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/IER3"},"hgnc":{"alias_symbol":["IEX-1","DIF-2","PRG1","IEX-1L"],"prev_symbol":[]},"alphafold":{"accession":"P46695","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P46695","model_url":"https://alphafold.ebi.ac.uk/files/AF-P46695-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P46695-F1-predicted_aligned_error_v6.png","plddt_mean":65.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=IER3","jax_strain_url":"https://www.jax.org/strain/search?query=IER3"},"sequence":{"accession":"P46695","fasta_url":"https://rest.uniprot.org/uniprotkb/P46695.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P46695/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P46695"}},"corpus_meta":[{"pmid":"18571452","id":"PMC_18571452","title":"PRG-1 and 21U-RNAs interact to form the piRNA complex required for fertility in C. elegans.","date":"2008","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/18571452","citation_count":458,"is_preprint":false},{"pmid":"9703517","id":"PMC_9703517","title":"IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9703517","citation_count":385,"is_preprint":false},{"pmid":"18501605","id":"PMC_18501605","title":"A C. elegans Piwi, PRG-1, regulates 21U-RNAs during spermatogenesis.","date":"2008","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/18501605","citation_count":222,"is_preprint":false},{"pmid":"16456541","id":"PMC_16456541","title":"B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16456541","citation_count":185,"is_preprint":false},{"pmid":"21112119","id":"PMC_21112119","title":"Role of the immediate early response 3 (IER3) gene in cellular stress response, inflammation and tumorigenesis.","date":"2010","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21112119","citation_count":157,"is_preprint":false},{"pmid":"19766573","id":"PMC_19766573","title":"Synaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19766573","citation_count":122,"is_preprint":false},{"pmid":"12510147","id":"PMC_12510147","title":"Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis.","date":"2003","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/12510147","citation_count":110,"is_preprint":false},{"pmid":"12730698","id":"PMC_12730698","title":"A new phospholipid phosphatase, PRG-1, is involved in axon growth and regenerative sprouting.","date":"2003","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12730698","citation_count":110,"is_preprint":false},{"pmid":"12356731","id":"PMC_12356731","title":"IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12356731","citation_count":98,"is_preprint":false},{"pmid":"3355503","id":"PMC_3355503","title":"Structure elucidation of two differentiation inducing factors (DIF-2 and DIF-3) from the cellular slime mould Dictyostelium discoideum.","date":"1988","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/3355503","citation_count":91,"is_preprint":false},{"pmid":"11782530","id":"PMC_11782530","title":"Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11782530","citation_count":86,"is_preprint":false},{"pmid":"17200115","id":"PMC_17200115","title":"Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activity.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17200115","citation_count":78,"is_preprint":false},{"pmid":"30579899","id":"PMC_30579899","title":"LncRNA GAS5 confers the radio sensitivity of cervical cancer cells via regulating miR-106b/IER3 axis.","date":"2018","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/30579899","citation_count":77,"is_preprint":false},{"pmid":"11244505","id":"PMC_11244505","title":"Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11244505","citation_count":77,"is_preprint":false},{"pmid":"22798682","id":"PMC_22798682","title":"Enhanced Th17 differentiation and aggravated arthritis in IEX-1-deficient mice by mitochondrial reactive oxygen species-mediated signaling.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22798682","citation_count":68,"is_preprint":false},{"pmid":"20467439","id":"PMC_20467439","title":"ATM-dependent expression of IEX-1 controls nuclear accumulation of Mcl-1 and the DNA damage response.","date":"2010","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/20467439","citation_count":64,"is_preprint":false},{"pmid":"11753682","id":"PMC_11753682","title":"IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11753682","citation_count":63,"is_preprint":false},{"pmid":"9781666","id":"PMC_9781666","title":"The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.","date":"1998","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9781666","citation_count":61,"is_preprint":false},{"pmid":"19096392","id":"PMC_19096392","title":"IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation.","date":"2008","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19096392","citation_count":59,"is_preprint":false},{"pmid":"24184684","id":"PMC_24184684","title":"Thrombopoietin promotes NHEJ DNA repair in hematopoietic stem cells through specific activation of Erk and NF-κB pathways and their target, IEX-1.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24184684","citation_count":55,"is_preprint":false},{"pmid":"9092801","id":"PMC_9092801","title":"Identification of PRG1, a novel progestin-responsive gene with sequence homology to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.","date":"1997","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9092801","citation_count":53,"is_preprint":false},{"pmid":"11934837","id":"PMC_11934837","title":"Identification of IEX-1 as a biomechanically controlled nuclear factor-kappaB target gene that inhibits cardiomyocyte hypertrophy.","date":"2002","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/11934837","citation_count":52,"is_preprint":false},{"pmid":"24311782","id":"PMC_24311782","title":"Modulation of nuclear factor E2-related factor-2 (Nrf2) activation by the stress response gene immediate early response-3 (IER3) in colonic epithelial cells: a novel mechanism of cellular adaption to inflammatory stress.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24311782","citation_count":50,"is_preprint":false},{"pmid":"16567805","id":"PMC_16567805","title":"Distinct domains for anti- and pro-apoptotic activities of IEX-1.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16567805","citation_count":49,"is_preprint":false},{"pmid":"31636893","id":"PMC_31636893","title":"LncRNA H19 over-expression inhibited Th17 cell differentiation to relieve endometriosis through miR-342-3p/IER3 pathway.","date":"2019","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/31636893","citation_count":47,"is_preprint":false},{"pmid":"11844788","id":"PMC_11844788","title":"Divergent regulation of the growth-promoting gene IEX-1 by the p53 tumor suppressor and Sp1.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11844788","citation_count":46,"is_preprint":false},{"pmid":"26671989","id":"PMC_26671989","title":"Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP.","date":"2016","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26671989","citation_count":45,"is_preprint":false},{"pmid":"17704804","id":"PMC_17704804","title":"The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17704804","citation_count":44,"is_preprint":false},{"pmid":"12360408","id":"PMC_12360408","title":"Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12360408","citation_count":44,"is_preprint":false},{"pmid":"8653710","id":"PMC_8653710","title":"PRG1: a novel early-response gene transcriptionally induced by pituitary adenylate cyclase activating polypeptide in a pancreatic carcinoma cell line.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8653710","citation_count":43,"is_preprint":false},{"pmid":"25250570","id":"PMC_25250570","title":"IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/25250570","citation_count":43,"is_preprint":false},{"pmid":"10720500","id":"PMC_10720500","title":"Respiratory syncytial virus infection induces expression of the anti-apoptosis gene IEX-1L in human respiratory epithelial cells.","date":"2000","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/10720500","citation_count":43,"is_preprint":false},{"pmid":"27453502","id":"PMC_27453502","title":"PRG-1 Regulates Synaptic Plasticity via Intracellular PP2A/β1-Integrin Signaling.","date":"2016","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/27453502","citation_count":43,"is_preprint":false},{"pmid":"9878538","id":"PMC_9878538","title":"A novel immediate early response gene, IEX-1, is induced by ultraviolet radiation in human keratinocytes.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9878538","citation_count":42,"is_preprint":false},{"pmid":"11455449","id":"PMC_11455449","title":"Expression of an immediate early gene, IEX-1, in human tissues.","date":"2001","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11455449","citation_count":41,"is_preprint":false},{"pmid":"15781630","id":"PMC_15781630","title":"p73beta-Mediated apoptosis requires p57kip2 induction and IEX-1 inhibition.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15781630","citation_count":40,"is_preprint":false},{"pmid":"12743274","id":"PMC_12743274","title":"The stress-inducible immediate-early responsive gene IEX-1 is activated in cells infected with herpes simplex virus 1, but several viral mechanisms, including 3' degradation of its RNA, preclude expression of the gene.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/12743274","citation_count":40,"is_preprint":false},{"pmid":"9627114","id":"PMC_9627114","title":"The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9627114","citation_count":38,"is_preprint":false},{"pmid":"12761504","id":"PMC_12761504","title":"The early response gene IEX-1 attenuates NF-kappaB activation in 293 cells, a possible counter-regulatory process leading to enhanced cell death.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12761504","citation_count":37,"is_preprint":false},{"pmid":"9791001","id":"PMC_9791001","title":"Regulation of a novel immediate early response gene, IEX-1, in keratinocytes by 1alpha,25-dihydroxyvitamin D3.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9791001","citation_count":36,"is_preprint":false},{"pmid":"19773435","id":"PMC_19773435","title":"Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromes.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19773435","citation_count":36,"is_preprint":false},{"pmid":"25666857","id":"PMC_25666857","title":"IER3 is a crucial mediator of TAp73β-induced apoptosis in cervical cancer and confers etoposide sensitivity.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25666857","citation_count":33,"is_preprint":false},{"pmid":"11311240","id":"PMC_11311240","title":"Functional disruption of IEX-1 expression by concatemeric hammerhead ribozymes alters growth properties of 293 cells.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11311240","citation_count":33,"is_preprint":false},{"pmid":"14592999","id":"PMC_14592999","title":"Biomechanically induced gene iex-1 inhibits vascular smooth muscle cell proliferation and neointima formation.","date":"2003","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/14592999","citation_count":33,"is_preprint":false},{"pmid":"25621074","id":"PMC_25621074","title":"MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2.","date":"2014","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/25621074","citation_count":32,"is_preprint":false},{"pmid":"18191642","id":"PMC_18191642","title":"IEX-1 directly interferes with RelA/p65 dependent transactivation and regulation of apoptosis.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/18191642","citation_count":32,"is_preprint":false},{"pmid":"10231843","id":"PMC_10231843","title":"Human PACAP response gene 1 (p22/PRG1): proliferation-associated expression in pancreatic carcinoma cells.","date":"1999","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/10231843","citation_count":32,"is_preprint":false},{"pmid":"10448082","id":"PMC_10448082","title":"The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10448082","citation_count":32,"is_preprint":false},{"pmid":"9588170","id":"PMC_9588170","title":"Genomic organization, promoter cloning, and chromosomal localization of the Dif-2 gene.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9588170","citation_count":32,"is_preprint":false},{"pmid":"26973248","id":"PMC_26973248","title":"Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26973248","citation_count":30,"is_preprint":false},{"pmid":"32183688","id":"PMC_32183688","title":"Identification of the ABCC4, IER3, and CBFA2T2 candidate genes for resistance to paratuberculosis from sequence-based GWAS in Holstein and Normande dairy cattle.","date":"2020","source":"Genetics, selection, evolution : GSE","url":"https://pubmed.ncbi.nlm.nih.gov/32183688","citation_count":29,"is_preprint":false},{"pmid":"20653564","id":"PMC_20653564","title":"Identification and characterization of PRG-1 as a neuronal calmodulin-binding protein.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20653564","citation_count":29,"is_preprint":false},{"pmid":"25036043","id":"PMC_25036043","title":"The role of Iex-1 in the pathogenesis of venous neointimal hyperplasia associated with hemodialysis arteriovenous fistula.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25036043","citation_count":29,"is_preprint":false},{"pmid":"19059322","id":"PMC_19059322","title":"ZnT-1, ZnT-3, CaMK II, PRG-1 expressions in hippocampus following neonatal seizure-induced cognitive deficit in rats.","date":"2008","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/19059322","citation_count":29,"is_preprint":false},{"pmid":"8134345","id":"PMC_8134345","title":"Mutations in PRG1, a yeast proteasome-related gene, cause defects in nuclear division and are suppressed by deletion of a mitotic cyclin gene.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8134345","citation_count":29,"is_preprint":false},{"pmid":"14534530","id":"PMC_14534530","title":"Development of T-cell lymphomas in Emu-IEX-1 mice.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14534530","citation_count":28,"is_preprint":false},{"pmid":"16973576","id":"PMC_16973576","title":"Herpes simplex virus ICP27 is required for virus-induced stabilization of the ARE-containing IEX-1 mRNA encoded by the human IER3 gene.","date":"2006","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/16973576","citation_count":28,"is_preprint":false},{"pmid":"19714745","id":"PMC_19714745","title":"Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB.","date":"2010","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19714745","citation_count":27,"is_preprint":false},{"pmid":"34671215","id":"PMC_34671215","title":"PRG-1 relieves pain and depressive-like behaviors in rats of bone cancer pain by regulation of dendritic spine in hippocampus.","date":"2021","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34671215","citation_count":26,"is_preprint":false},{"pmid":"22417305","id":"PMC_22417305","title":"Resistance of Sézary cells to TNF-α-induced apoptosis is mediated in part by a loss of TNFR1 and a high level of the IER3 expression.","date":"2012","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/22417305","citation_count":25,"is_preprint":false},{"pmid":"16166241","id":"PMC_16166241","title":"Elevated blood pressure and cardiac hypertrophy after ablation of the gly96/IEX-1 gene.","date":"2005","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/16166241","citation_count":25,"is_preprint":false},{"pmid":"22085302","id":"PMC_22085302","title":"Clinical significance of IEX-1 expression in ovarian carcinoma.","date":"2011","source":"Ultrastructural pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22085302","citation_count":23,"is_preprint":false},{"pmid":"12032839","id":"PMC_12032839","title":"Characterization of a novel hexameric repeat DNA sequence in the promoter of the immediate early gene, IEX-1, that mediates 1alpha,25-dihydroxyvitamin D(3)-associated IEX-1 gene repression.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12032839","citation_count":22,"is_preprint":false},{"pmid":"28843862","id":"PMC_28843862","title":"Altered synaptic phospholipid signaling in PRG-1 deficient mice induces exploratory behavior and motor hyperactivity resembling psychiatric disorders.","date":"2017","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/28843862","citation_count":21,"is_preprint":false},{"pmid":"27767172","id":"PMC_27767172","title":"Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27767172","citation_count":19,"is_preprint":false},{"pmid":"27063893","id":"PMC_27063893","title":"IEX-1 deficiency induces browning of white adipose tissue and resists diet-induced obesity.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27063893","citation_count":18,"is_preprint":false},{"pmid":"24056813","id":"PMC_24056813","title":"Stress-induced hematopoietic failure in the absence of immediate early response gene X-1 (IEX-1, IER3).","date":"2013","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/24056813","citation_count":18,"is_preprint":false},{"pmid":"19285955","id":"PMC_19285955","title":"IEX-1-induced cell death requires BIM and is modulated by MCL-1.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19285955","citation_count":18,"is_preprint":false},{"pmid":"12899517","id":"PMC_12899517","title":"A novel vitamin D-regulated immediate-early gene, IEX-1, alters cellular growth and apoptosis.","date":"2003","source":"Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12899517","citation_count":17,"is_preprint":false},{"pmid":"33472635","id":"PMC_33472635","title":"TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3.","date":"2021","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/33472635","citation_count":16,"is_preprint":false},{"pmid":"28353642","id":"PMC_28353642","title":"Dysregulated IER3 Expression is Associated with Enhanced Apoptosis in Titin-Based Dilated Cardiomyopathy.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28353642","citation_count":16,"is_preprint":false},{"pmid":"22550081","id":"PMC_22550081","title":"IEX-1 deficiency protects against colonic cancer.","date":"2012","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/22550081","citation_count":16,"is_preprint":false},{"pmid":"25466275","id":"PMC_25466275","title":"Mitochondrial anti-oxidant protects IEX-1 deficient mice from organ damage during endotoxemia.","date":"2014","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25466275","citation_count":15,"is_preprint":false},{"pmid":"15855159","id":"PMC_15855159","title":"Immediate early gene X1 (IEX-1) is organized in subnuclear structures and partially co-localizes with promyelocytic leukemia protein in HeLa cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15855159","citation_count":15,"is_preprint":false},{"pmid":"1850369","id":"PMC_1850369","title":"A possible role for DIF-2 in the formation of stalk cells during Dictyostelium development.","date":"1991","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/1850369","citation_count":14,"is_preprint":false},{"pmid":"21250941","id":"PMC_21250941","title":"IEX-1 suppresses apoptotic damage in human intestinal epithelial Caco-2 cells induced by co-culturing with macrophage-like THP-1 cells.","date":"2011","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/21250941","citation_count":14,"is_preprint":false},{"pmid":"15767410","id":"PMC_15767410","title":"Herpes simplex virus infection stabilizes cellular IEX-1 mRNA.","date":"2005","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/15767410","citation_count":13,"is_preprint":false},{"pmid":"18643870","id":"PMC_18643870","title":"Prg1 is regulated by the basic helix-loop-helix transcription factor Math2.","date":"2008","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18643870","citation_count":13,"is_preprint":false},{"pmid":"15120418","id":"PMC_15120418","title":"Immediate early gene X-1 (IEX-1), a hydroxytamoxifen regulated gene with increased stimulation in MCF-7 derived resistant breast cancer cells.","date":"2004","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15120418","citation_count":13,"is_preprint":false},{"pmid":"27256408","id":"PMC_27256408","title":"IF-combined smRNA FISH reveals interaction of MCPIP1 protein with IER3 mRNA.","date":"2016","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/27256408","citation_count":12,"is_preprint":false},{"pmid":"30257321","id":"PMC_30257321","title":"Additive antitumor effect of arsenic trioxide combined with intravesical bacillus Calmette-Guerin immunotherapy against bladder cancer through blockade of the IER3/Nrf2 pathway.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30257321","citation_count":11,"is_preprint":false},{"pmid":"27966779","id":"PMC_27966779","title":"Serum Levels of TIMP-3, LIPC, IER3, and SLC16A8 in CFH-Negative AMD Cases.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27966779","citation_count":11,"is_preprint":false},{"pmid":"27890615","id":"PMC_27890615","title":"EGR2 is a gonadotropin-induced survival factor that controls the expression of IER3 in ovarian granulosa cells.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27890615","citation_count":11,"is_preprint":false},{"pmid":"16960879","id":"PMC_16960879","title":"Immediate early gene IEX-1 induces astrocytic differentiation of U87-MG human glioma cells.","date":"2007","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16960879","citation_count":10,"is_preprint":false},{"pmid":"26986830","id":"PMC_26986830","title":"Activation of ERK/IER3/PP2A-B56γ-positive feedback loop in lung adenocarcinoma by allelic deletion of B56γ gene.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26986830","citation_count":10,"is_preprint":false},{"pmid":"25827082","id":"PMC_25827082","title":"IER3 Promotes Expansion of Adipose Progenitor Cells in Response to Changes in Distinct Microenvironmental Effectors.","date":"2015","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/25827082","citation_count":9,"is_preprint":false},{"pmid":"39354533","id":"PMC_39354533","title":"Comprehensive analysis of bulk, single-cell RNA sequencing, and spatial transcriptomics revealed IER3 for predicting malignant progression and immunotherapy efficacy in glioma.","date":"2024","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/39354533","citation_count":9,"is_preprint":false},{"pmid":"15306824","id":"PMC_15306824","title":"The expression of immediate early gene X-1 (IEX-1) is differentially induced by retinoic acids in NB4 and KG1 cells: possible implication in the distinct phenotype of retinoic acid-responsive and -resistant leukemic cells.","date":"2004","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/15306824","citation_count":9,"is_preprint":false},{"pmid":"18564103","id":"PMC_18564103","title":"Overexpression of immediate early gene X-1 (IEX-1) enhances gamma-radiation-induced apoptosis of human glioma cell line, U87-MG.","date":"2008","source":"Neuropathology : official journal of the Japanese Society of Neuropathology","url":"https://pubmed.ncbi.nlm.nih.gov/18564103","citation_count":9,"is_preprint":false},{"pmid":"40090972","id":"PMC_40090972","title":"IER3: exploring its dual function as an oncogene and tumor suppressor.","date":"2025","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/40090972","citation_count":8,"is_preprint":false},{"pmid":"29213350","id":"PMC_29213350","title":"Immediate Early Response Gene X-1 (IEX-1) Mediates Ischemic Preconditioning-Induced Cardioprotection in Rats.","date":"2017","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/29213350","citation_count":7,"is_preprint":false},{"pmid":"36093041","id":"PMC_36093041","title":"PRG-1 prevents neonatal stimuli-induced persistent hyperalgesia and memory dysfunction via NSF/Glu/GluR2 signaling.","date":"2022","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/36093041","citation_count":6,"is_preprint":false},{"pmid":"29101849","id":"PMC_29101849","title":"Molecular characterization of the bovine IER3 gene: Down-regulation of IL-8 by blocking NF-κB activity mediated by IER3 overexpression in MDBK cells infected with bovine viral diarrhea virus-1.","date":"2017","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29101849","citation_count":6,"is_preprint":false},{"pmid":"26687273","id":"PMC_26687273","title":"NT-3 protein levels are enhanced in the hippocampus of PRG1-deficient mice but remain unchanged in PRG1/LPA2 double mutants.","date":"2015","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/26687273","citation_count":5,"is_preprint":false},{"pmid":"27736946","id":"PMC_27736946","title":"Expression and Functions of Immediate Early Response Gene X-1 (IEX-1) in Rheumatoid Arthritis Synovial Fibroblasts.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27736946","citation_count":5,"is_preprint":false},{"pmid":"25066273","id":"PMC_25066273","title":"Transcription factor Elk-1 participates in the interleukin-1β-dependent regulation of expression of immediate early response gene 3 (IER3).","date":"2014","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/25066273","citation_count":5,"is_preprint":false},{"pmid":"24884413","id":"PMC_24884413","title":"The influences of PRG-1 on the expression of small RNAs and mRNAs.","date":"2014","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/24884413","citation_count":4,"is_preprint":false},{"pmid":"25684507","id":"PMC_25684507","title":"Expression of IER3 in primary hepatocarcinoma: correlation with clinicopathological parameters.","date":"2015","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/25684507","citation_count":4,"is_preprint":false},{"pmid":"40244862","id":"PMC_40244862","title":"Exercise-Mediated Mechanical Stress Promotes Osteogenic Differentiation of BMSCs Through Upregulation of Lactylation via the IER3/LDHB Axis.","date":"2025","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/40244862","citation_count":3,"is_preprint":false},{"pmid":"39331858","id":"PMC_39331858","title":"Unveiling the glycolysis in sepsis: Integrated bioinformatics and machine learning analysis identifies crucial roles for IER3, DSC2, and PPARG in disease pathogenesis.","date":"2024","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39331858","citation_count":3,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49415,"output_tokens":7728,"usd":0.132082},"stage2":{"model":"claude-opus-4-6","input_tokens":11537,"output_tokens":3996,"usd":0.236377},"total_usd":0.368459,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"IEX-1 (IER3) is transcriptionally induced by TNF in an NF-κB-dependent manner and protects cells from Fas- or TNF-induced apoptosis; overexpression of antisense IEX-1 sensitized cells to TNF-induced killing, establishing IEX-1 as a downstream NF-κB target mediating cell survival.\",\n      \"method\": \"Antisense overexpression, transfection of IEX-1 expression vector, cell viability assays in TNF/Fas-stimulated cells\",\n      \"journal\": \"Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function (antisense) and gain-of-function with defined apoptosis phenotype, single lab\",\n      \"pmids\": [\"9703517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The IEX-1 (p22/PRG1) promoter contains functional binding sites for p53 and NF-κB; gel shift/supershift assays confirmed direct binding of both transcription factors, and reporter assays demonstrated p53-dependent and TNF/NF-κB-dependent transactivation of the IEX-1 promoter.\",\n      \"method\": \"EMSA/supershift assay, CAT reporter gene assay, stable transfection with temperature-sensitive p53\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct DNA binding demonstrated by EMSA and functional promoter assays, replicated across multiple groups\",\n      \"pmids\": [\"9781666\", \"9627114\", \"11844788\", \"12360408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"IEX-1 is a direct substrate of ERK2; it is phosphorylated in vivo upon ERK activation, interacts specifically with phosphorylated ERKs (but not JNK or p38), and upon ERK-mediated phosphorylation acquires anti-apoptotic activity. Independently, IEX-1 potentiates ERK activation, with ERK-docking-site mutants abolishing this potentiation while phosphorylation-site mutants abolish survival signaling.\",\n      \"method\": \"Phosphorylation screening with active ERK2, in vivo phosphorylation assay, IEX-1 domain mutants (ERK phosphoacceptor and docking site mutations), cell death assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay plus in vivo phosphorylation plus structure-function mutagenesis in a single study\",\n      \"pmids\": [\"12356731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"B56-containing PP2A holoenzymes dephosphorylate ERK; IEX-1 binds directly to B56 subunits and to phosphorylated ERK, enabling ERK to transphosphorylate B56 at a conserved Ser/Pro site, which triggers dissociation of B56 from the PP2A catalytic subunit, thereby inhibiting ERK dephosphorylation and sustaining ERK activity.\",\n      \"method\": \"RNAi of B56 subunits, overexpression, co-immunoprecipitation, in vitro phosphatase assay, ERK phosphorylation assays, domain mutants\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted PP2A inhibition in vitro, reciprocal co-IP, mutagenesis, multiple orthogonal methods in one study\",\n      \"pmids\": [\"16456541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"IEX-1 inhibits B56-PP2A-mediated dephosphorylation of Akt on both Thr308 and Ser473, thereby sustaining Akt activity in an ERK-dependent manner; an IEX-1 mutant deficient in ERK binding had no effect on Akt, and B56β/γ mutants that cannot be phosphorylated by the ERK·IEX-1 complex showed enhanced ability to dephosphorylate Akt.\",\n      \"method\": \"Overexpression and RNAi of IEX-1 and B56 subunits, ERK dominant-negative mutants, phospho-Akt immunoblot, ERK-binding-deficient IEX-1 mutant\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches including dominant-negatives and structure-function mutants, mechanistically extending EMBO J 2006 findings\",\n      \"pmids\": [\"17200115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"IEX-1 overexpression in HeLa cells accelerates cell cycle progression and increases susceptibility to apoptosis induced by death-receptor ligands or etoposide; NF-κB-dependent induction of IEX-1 does not mediate NF-κB's anti-apoptotic effect but instead modulates cell cycle.\",\n      \"method\": \"Inducible IEX-1 expression vector, antisense hammerhead ribozyme knockdown, apoptosis and cell cycle assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain-of-function and loss-of-function with defined apoptosis phenotype, single lab\",\n      \"pmids\": [\"11244505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Transgenic expression of IEX-1 specifically in T cells impairs Fas- and TCR/CD3-induced apoptosis, extends the effector phase of immune responses, and leads to lupus-like autoimmunity and T-cell lymphomas in aging mice, demonstrating a T-cell-specific anti-apoptotic role in vivo.\",\n      \"method\": \"Eμ-IEX-1 transgenic mice, T cell apoptosis assays (Fas/TCR ligation), immune response phenotyping, lymphoma analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model with defined molecular mechanism, replicated in separate transgenic study\",\n      \"pmids\": [\"11782530\", \"14534530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"IEX-1 attenuation of NF-κB activation involves inhibition of the 26S proteasome and altered IκBα turnover; IEX-1 overexpression decreases nuclear p65 accumulation and NF-κB reporter activity, while IEX-1 disruption by ribozymes increases NF-κB activity and decreases apoptotic sensitivity.\",\n      \"method\": \"Stable inducible IEX-1 overexpression, anti-IEX-1 hammerhead ribozyme knockdown, gel-shift and luciferase reporter assays, fluorometric proteasome assay, immunofluorescence for nuclear p65\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function with multiple mechanistic readouts, single lab\",\n      \"pmids\": [\"12761504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"IEX-1 directly binds the C-terminal transactivation domain of RelA/p65 (shown by GST pulldown and confirmed by endogenous co-immunoprecipitation), inhibits RelA/p65-dependent transactivation, reduces expression of anti-apoptotic NF-κB targets (Bcl-2, Bcl-xL, cIAP1, cIAP2), and associates with their promoters (ChIP assay).\",\n      \"method\": \"GST pulldown, co-immunoprecipitation, GAL4/luciferase reporter assay, chromatin immunoprecipitation (ChIP), deletion constructs of IEX-1\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct protein interaction verified by GST-pulldown and reciprocal co-IP, functional consequence demonstrated by reporter and ChIP assays\",\n      \"pmids\": [\"18191642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IEX-1 targets the mitochondrial F1Fo-ATPase inhibitor (IF1) for degradation via interaction with the C-terminus of IF1, leading to acceleration of ATP hydrolysis, reduction of mitochondrial ROS production, and a metabolic shift from oxidative phosphorylation to glycolysis; IEX-1 knockout mice show stabilized IF1 and reduced mitochondrial ATPase activity in vivo.\",\n      \"method\": \"Co-immunoprecipitation, C-terminal truncation studies, siRNA knockdown of IF1, IEX-1 knockout mice, ATP hydrolysis assay, ROS measurement, metabolic assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct interaction mapped to specific domain, siRNA phenocopy, in vivo knockout validation with biochemical readout\",\n      \"pmids\": [\"19096392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"IEX-1 localizes to distinct subnuclear structures in a nuclear-localization-sequence-dependent manner, partially co-localizes with PML nuclear bodies, physically interacts with PML (shown by co-immunoprecipitation), and is subject to nucleocytoplasmic shuttling via CRM1; loss of the NLS impairs pro-apoptotic but not anti-apoptotic function.\",\n      \"method\": \"Confocal microscopy of GFP-IEX-1 fusion protein, double immunofluorescence, leptomycin B treatment, co-immunoprecipitation with PML isoforms, NLS deletion mutant apoptosis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal localization methods plus functional mutagenesis and direct interaction by co-IP\",\n      \"pmids\": [\"15855159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"IEX-1 anti- and pro-apoptotic activities map to distinct protein domains: a transmembrane-like hydrophobic region is critical for both functions; N-linked glycosylation sites, phosphorylation sites, and the C-terminus are required for anti-apoptotic but not pro-apoptotic activity; the nuclear localization sequence is required for pro-apoptotic but not anti-apoptotic activity; anti-apoptotic mutants all fail to suppress acute mitochondrial ROS production.\",\n      \"method\": \"Site-directed mutagenesis of hydrophobic residues, glycosylation/phosphorylation sites, NLS; apoptosis assays; intracellular ROS measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic structure-function mutagenesis with multiple functional readouts in a single study\",\n      \"pmids\": [\"16567805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"IEX-1 interacts with the anti-apoptotic protein MCL-1 (identified by yeast two-hybrid and confirmed by endogenous co-immunoprecipitation); IEX-1-induced caspase-dependent apoptosis requires BIM but not NOXA or PUMA, and is modulated by MCL-1 expression levels.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation in human cells, BIM/NOXA/PUMA knockout cells, caspase assay, mitochondrial membrane potential assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — interaction confirmed by endogenous co-IP and mechanistically linked to BIM-dependent apoptosis via genetic knockouts\",\n      \"pmids\": [\"19285955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"IEX-1 (IER3) interacts with MCL-1 and is required for ATM-dependent nuclear translocation of MCL-1 in response to DNA damage; IEX-1 is rapidly induced by γ-irradiation in an ATM-dependent manner; loss of IEX-1 prevents Mcl-1 nuclear accumulation, impairs Chk1 activation and G2 checkpoint arrest, and leads to genomic instability; proteasomal degradation of IEX-1 reverses Mcl-1 to the cytosol.\",\n      \"method\": \"IEX-1 knockdown/knockout, ATM inhibition, γ-irradiation, nuclear fractionation, co-immunoprecipitation, Chk1 phosphorylation assay, genomic instability assay\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, genetic and pharmacological manipulation, clearly defined molecular pathway\",\n      \"pmids\": [\"20467439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TPO specifically activates ERK and NF-κB pathways in hematopoietic stem and progenitor cells; both pathways cooperate to induce IEX-1 upon DNA damage; IEX-1 forms a complex with phospho-ERK and the catalytic subunit of DNA-PK, which is necessary and sufficient for TPO-increased DNA-PK activation and NHEJ repair in mouse and human HSPCs.\",\n      \"method\": \"Signaling pathway inhibitors, IEX-1 knockdown and overexpression, co-immunoprecipitation of IEX-1/pERK/DNA-PKcs complex, NHEJ repair assay, DNA-PK phosphorylation assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ternary complex identified by co-IP, loss- and gain-of-function with defined biochemical phenotype, validated in both mouse and human cells\",\n      \"pmids\": [\"24184684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"IEX-1 deficiency promotes Th17 differentiation and impairs Th1 cell survival through increased mitochondrial ROS production following T cell activation; mitochondrial ROS augment B cell-activating transcription factor expression contributing to IL-17 production; ROS scavengers or mitochondria-specific antioxidants inhibit Th17 induction in IEX-1 KO mice.\",\n      \"method\": \"IEX-1 knockout mice, collagen-induced arthritis model, mitochondrial ROS measurement, N-acetylcysteine/mitoquinone treatment, flow cytometry for Th17/Th1, IL-17 ELISA\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with mechanistically defined pathway, pharmacological rescue experiments, multiple orthogonal readouts\",\n      \"pmids\": [\"22798682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IEX-1 modulates Nrf2 activity through the PI3K/Akt-Fyn pathway in colonic epithelial cells; IER3 deficiency (KO mice or shRNA knockdown) increases Nrf2 nuclear accumulation and target gene expression; IER3 deficiency reduces ROS and decreases apoptotic sensitivity; PI3K inhibition or Akt/Fyn knockdown abrogates IER3-deficiency-induced Nrf2 activation.\",\n      \"method\": \"Ier3 knockout mice, shRNA knockdown, IER3 overexpression, Nrf2 nuclear fractionation, Nrf2 target gene qPCR, PI3K inhibitor, siRNA knockdown of Akt and Fyn, ROS measurement, clonogenicity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO combined with in vitro mechanistic dissection using pathway inhibitors and multiple knockdowns\",\n      \"pmids\": [\"24311782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"IER3 sustains ERK1/2 phosphorylation in pancreatic cancer cells by inhibiting PP2A phosphatase activity; IER3 expression is required for KrasG12D-driven PanIN and PDAC development in vivo, and IER3-deficient KrasG12D mice show delayed PanIN and PDAC formation.\",\n      \"method\": \"IER3 overexpression and knockdown in human pancreatic cancer cells, PP2A phosphatase activity assay, IER3/KrasG12D double mutant mice, immunohistochemistry for pERK1/2 and IER3\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro phosphatase assay plus in vivo genetic model with defined oncogenic pathway\",\n      \"pmids\": [\"25250570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MDM2 is the E3 ubiquitin ligase responsible for IER3 ubiquitination and proteasomal degradation; polyubiquitination at lysine 60 of IER3 is essential; FHL2 acts as a scaffold protein that binds both IER3 and MDM2, facilitating efficient MDM2-mediated IER3 degradation.\",\n      \"method\": \"Co-immunoprecipitation of MDM2-IER3-FHL2 ternary complex, ubiquitination assay, K60 point mutant of IER3, FHL2/MDM2 siRNA knockdown, proteasome inhibitor, cell cycle assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct ubiquitination assay with specific residue identified, ternary complex defined by co-IP, mechanistic rescue experiments\",\n      \"pmids\": [\"26973248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In vascular smooth muscle cells, IEX-1 expression induced by NF-κB (abolished by IκBα overexpression) inhibits cell cycle progression by reducing p27kip1 degradation and Rb hyperphosphorylation; adenoviral IEX-1 overexpression in vivo reduces neointima formation after carotid artery injury.\",\n      \"method\": \"Northern and Western blot, adenoviral gene transfer, 3H-thymidine incorporation, p27kip1 immunoblot, Rb phosphorylation assay, in vivo carotid injury model, histomorphometry\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro mechanistic pathway with cell cycle targets plus in vivo validation, NF-κB pathway placed by IκBα overexpression\",\n      \"pmids\": [\"14592999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"In cardiomyocytes, IEX-1 is induced by biomechanical strain in an NF-κB-dependent manner (abolished by IκBα overexpression), and adenoviral overexpression of IEX-1 abolishes cardiomyocyte hypertrophy induced by mechanical strain, phenylephrine, or endothelin-1 without affecting cell viability.\",\n      \"method\": \"In vivo pressure overload model, in vitro mechanical stimulation, adenoviral IEX-1 overexpression, IκBα overexpression, Northern/Western blot, hypertrophy readouts\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro model with NF-κB pathway placement and gain-of-function phenotype, single lab\",\n      \"pmids\": [\"11934837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HSV-1 ICP27 stabilizes ARE-containing IEX-1 mRNA by activating the p38/MK2 MAPK pathway; ICP27 mutants deficient in p38 activation fail to stabilize IEX-1 mRNA, and the p38 inhibitor SB203580 abrogates IEX-1 mRNA stabilization, whereas the virion host shutoff protein (vhs) plays little role.\",\n      \"method\": \"Panel of ICP27 mutant HSV-1 isolates, actinomycin D mRNA stability assay, p38 inhibitor SB203580, Northern blot/real-time PCR\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic panel of mutants with pharmacological rescue defines ICP27/p38 as stabilization mechanism\",\n      \"pmids\": [\"16973576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TAp73β transcriptionally activates IER3 in cervical cancer cells (whereas p53 and TAp63 do not); IER3 silencing suppresses TAp73β-induced apoptosis but not p53-induced apoptosis; etoposide upregulates TAp73β and IER3 through c-Abl kinase, and etoposide chemosensitivity is largely determined by the TAp73β-IER3 axis.\",\n      \"method\": \"Luciferase reporter assay, IER3 siRNA knockdown, p53/TAp63/TAp73β expression vectors, c-Abl inhibition, apoptosis assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transcriptional specificity established by reporter assay, siRNA epistasis places IER3 downstream of c-Abl/TAp73β\",\n      \"pmids\": [\"25666857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"IEX-1 deficiency induces browning of white adipose tissue and promotes alternative activation of adipose macrophages, leading to increased thermogenic gene expression (e.g., UCP1), enhanced thermogenesis, and resistance to high-fat diet-induced obesity; IEX-1 is a negative regulator of WAT browning.\",\n      \"method\": \"IEX-1 knockout mice, high-fat diet feeding, gene expression profiling of thermogenic genes, energy expenditure measurement, macrophage polarization assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with mechanistic pathway (macrophage polarization driving browning), but detailed molecular mechanism of IEX-1 action not fully resolved\",\n      \"pmids\": [\"27063893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MCPIP1 RNase interacts with IER3 mRNA via a stem-loop structure in the IER3 3'UTR and degrades it; deletion of the stem-loop abolishes MCPIP1-mediated destabilization; IF-combined smRNA FISH confirms co-localization of MCPIP1 protein with IER3 mRNA in cells; RNA immunoprecipitation confirms MCPIP1-IER3 mRNA interaction in vivo.\",\n      \"method\": \"Dual luciferase assay with IER3 3'UTR constructs, deletion mutagenesis of stem-loop, immunofluorescence-combined single-molecule RNA FISH, RNA immunoprecipitation\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA-protein interaction confirmed by RIP and smRNA FISH, deletion mutant identifies functional element\",\n      \"pmids\": [\"27256408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"IL-1β-induced IER3 expression is mediated through ERK1/2 and transcription factor Elk-1; Elk-1 is phosphorylated by ERK and binds ETS5/6 sequences in the IER3 promoter; mutation of ETS5/6 abolishes IL-1β-induced and constitutively active Elk-1-driven IER3 promoter activity.\",\n      \"method\": \"Promoter-luciferase reporter assay, EMSA, site-directed mutagenesis of ETS binding sites, constitutively active Elk-1 (Elk-VP16), Elk-1 phosphorylation immunoblot\",\n      \"journal\": \"Cytokine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EMSA and mutagenesis define promoter element; gain-of-function with constitutively active Elk-1 confirms mechanism\",\n      \"pmids\": [\"25066273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IEX-1 overexpression in HeLa cells induces astrocytic differentiation phenotype in U87-MG glioma cells (increased S-100 and GFAP); IEX-1 acts downstream of PKA in cAMP-induced astrocytic differentiation, as antisense IEX-1 abolishes dbcAMP-induced morphological changes, while IEX-1-induced differentiation is not blocked by PKA inhibitor H89.\",\n      \"method\": \"IEX-1 transfection, antisense RNA disruption, dbcAMP stimulation, PKA inhibitor H89, GFAP/S-100 immunoblot, morphological analysis\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single antisense approach with limited mechanistic resolution of pathway position\",\n      \"pmids\": [\"16960879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"EGR2 is a transcription factor downstream of gonadotropins that directly transactivates IER3 in granulosa cells; EGR2 binds EGR-binding elements in the IER3 promoter (confirmed by EMSA, ChIP, luciferase assay); EGR2-promoted cell survival requires IER3 as a mediator, and EGR2 also regulates MCL-1 expression.\",\n      \"method\": \"Luciferase reporter assay, EMSA, ChIP, EGR2 overexpression and knockdown, IER3 knockdown, cell survival assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods confirming transcriptional regulation; epistasis established by IER3 knockdown reversing EGR2 survival effect\",\n      \"pmids\": [\"27890615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TRAIL physically interacts with IER3 (shown by co-immunoprecipitation and immunofluorescence co-localization) in hepatocellular carcinoma cells; TRAIL and IER3 cooperate to inhibit Wnt/β-catenin signaling, thereby inducing apoptosis and reducing proliferation and migration both in vitro and in vivo.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, Wnt/β-catenin pathway reporter/immunoblot, apoptosis/proliferation/migration assays, xenograft model\",\n      \"journal\": \"Cancer cell international\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP and co-localization without detailed mechanistic dissection of the direct interaction\",\n      \"pmids\": [\"33472635\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"IER3 is a stress-inducible, NF-κB/p53/ERK-regulated immediate-early gene whose protein acts as a dual-function regulator of cell survival: it binds and inhibits B56-containing PP2A holoenzymes (by enabling ERK-mediated phosphorylation of B56 subunits), thereby sustaining both ERK and Akt phosphorylation; directly interacts with RelA/p65 to attenuate NF-κB transactivation; targets the mitochondrial ATPase inhibitor IF1 for degradation to suppress ROS production; interacts with MCL-1 to control its ATM-dependent nuclear translocation and DNA damage checkpoint function; forms a complex with pERK and DNA-PKcs to promote NHEJ repair; and undergoes MDM2-FHL2-mediated ubiquitination at K60 for proteasomal degradation, with its nucleocytoplasmic distribution and functional output (pro- or anti-apoptotic) determined by distinct structural domains including a transmembrane-like hydrophobic region, glycosylation/phosphorylation sites, and a nuclear localization sequence.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"IER3 is a stress-inducible immediate-early gene that functions as a context-dependent regulator of cell survival, apoptosis, and DNA damage responses by modulating multiple signaling cascades. Its principal biochemical activity is inhibition of B56-containing PP2A holoenzymes: IER3 binds B56 subunits and phosphorylated ERK, enabling ERK-mediated transphosphorylation of B56 that dissociates B56 from PP2A catalytic subunits, thereby sustaining both ERK and Akt phosphorylation [PMID:16456541, PMID:17200115, PMID:25250570]. IER3 also directly binds RelA/p65 to attenuate NF-κB transactivation of anti-apoptotic targets [PMID:18191642], targets the mitochondrial ATPase inhibitor IF1 for degradation to suppress ROS production [PMID:19096392], and forms a complex with phospho-ERK and DNA-PKcs to promote NHEJ repair in hematopoietic stem cells [PMID:24184684]. IER3 protein stability is controlled by MDM2-mediated ubiquitination at K60, scaffolded by FHL2, and its pro- versus anti-apoptotic output is determined by distinct structural domains including a nuclear localization sequence required for pro-apoptotic function and glycosylation/phosphorylation sites required for anti-apoptotic function [PMID:26973248, PMID:16567805].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"IER3 was established as an NF-κB- and p53-responsive immediate-early gene with anti-apoptotic function, answering whether NF-κB transcriptional targets directly mediate cell survival after TNF/Fas signaling.\",\n      \"evidence\": \"Antisense knockdown sensitized cells to TNF-induced killing; EMSA and reporter assays confirmed direct p53 and NF-κB binding to the IER3 promoter in multiple cell lines\",\n      \"pmids\": [\"9703517\", \"9781666\", \"9627114\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effector mechanism of IER3-mediated survival was unknown\", \"Relative contributions of p53 vs NF-κB to physiological IER3 induction were not delineated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"IER3 was identified as a direct ERK2 substrate whose phosphorylation is required for anti-apoptotic activity, and reciprocally, IER3 potentiates ERK activation — establishing a positive feedback loop between IER3 and MAPK signaling.\",\n      \"evidence\": \"In vitro kinase assay with ERK2, in vivo phosphorylation, ERK-docking-site and phosphoacceptor mutants with cell death assays\",\n      \"pmids\": [\"12356731\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The direct molecular target through which IER3 potentiates ERK was not identified\", \"Whether ERK phosphorylation of IER3 controls its stability or localization was unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Transgenic mouse models demonstrated that IER3 overexpression in T cells impairs Fas- and TCR-induced apoptosis in vivo, leading to autoimmunity and lymphomagenesis — establishing IER3's in vivo relevance to immune homeostasis.\",\n      \"evidence\": \"Eμ-IER3 transgenic mice with T cell apoptosis assays, immune response phenotyping, and lymphoma analysis\",\n      \"pmids\": [\"11782530\", \"14534530\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target in the Fas/TCR death pathway inhibited by IER3 was not identified\", \"Whether IER3 effects were cell-autonomous in vivo was not fully resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"IER3 was shown to undergo nucleocytoplasmic shuttling and to co-localize with PML nuclear bodies, with its NLS required selectively for pro-apoptotic function — resolving how a single protein can exert opposing effects on cell fate depending on subcellular compartment.\",\n      \"evidence\": \"GFP-IER3 confocal microscopy, leptomycin B treatment, co-IP with PML, NLS deletion mutant apoptosis assays\",\n      \"pmids\": [\"15855159\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The nuclear target(s) mediating IER3's pro-apoptotic function were not identified\", \"Functional significance of PML body association was not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The mechanism of ERK potentiation was solved: IER3 inhibits B56-containing PP2A holoenzymes by bridging phospho-ERK to B56 subunits, enabling ERK-mediated transphosphorylation and dissociation of B56 from the PP2A catalytic subunit — identifying IER3 as a PP2A inhibitor.\",\n      \"evidence\": \"Reciprocal co-IP, in vitro phosphatase assay reconstitution, RNAi of B56 subunits, domain mutagenesis\",\n      \"pmids\": [\"16456541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether IER3 inhibits PP2A complexes containing other B-family subunits was not tested\", \"Structural basis of the IER3–B56 interaction was unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Systematic structure-function analysis mapped anti-apoptotic activity to glycosylation/phosphorylation sites and the C-terminus, and pro-apoptotic activity to the NLS, with both requiring a transmembrane-like hydrophobic region — establishing that dual functionality is encoded in separable protein domains.\",\n      \"evidence\": \"Site-directed mutagenesis of hydrophobic residues, glycosylation sites, phosphorylation sites, NLS; apoptosis and ROS assays\",\n      \"pmids\": [\"16567805\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether post-translational modifications control domain switching in physiological settings was not shown\", \"The transmembrane-like region's membrane insertion and topology were not resolved structurally\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"IER3-mediated PP2A inhibition was extended to the Akt pathway: IER3 sustains Akt phosphorylation at Thr308 and Ser473 via B56-PP2A inhibition in an ERK-dependent manner, linking IER3 to two major survival kinase cascades simultaneously.\",\n      \"evidence\": \"Overexpression and RNAi of IER3 and B56 subunits, ERK dominant-negative mutants, phospho-Akt immunoblot, ERK-binding-deficient IER3 mutant\",\n      \"pmids\": [\"17200115\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Akt sustaining is the primary mechanism of IER3's anti-apoptotic activity versus other targets was not determined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The negative-feedback role of IER3 on NF-κB was mechanistically defined: IER3 directly binds the RelA/p65 transactivation domain, represses NF-κB target genes (Bcl-2, Bcl-xL, cIAP1/2), and associates with their promoters — explaining how an NF-κB-induced gene can attenuate its own inducer.\",\n      \"evidence\": \"GST pulldown, endogenous co-IP, GAL4/luciferase reporter, ChIP on anti-apoptotic gene promoters\",\n      \"pmids\": [\"18191642\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether IER3–p65 interaction competes with coactivators or recruits corepressors was not resolved\", \"Chromatin-level mechanism of repression was not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"IER3 was found to target the mitochondrial F1Fo-ATPase inhibitor IF1 for degradation, accelerating ATP hydrolysis and reducing mitochondrial ROS — providing a direct metabolic mechanism for IER3's effects on ROS and explaining the ROS phenotype of IER3-knockout mice.\",\n      \"evidence\": \"Co-IP mapping to IF1 C-terminus, IF1 siRNA phenocopy, IER3 KO mice with stabilized IF1, ATP hydrolysis and ROS assays\",\n      \"pmids\": [\"19096392\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The degradation pathway (proteasomal vs lysosomal) through which IER3 eliminates IF1 was not defined\", \"Whether IF1 degradation fully accounts for IER3's metabolic effects was untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"IER3 was shown to interact with MCL-1 and to be required for ATM-dependent nuclear translocation of MCL-1 after DNA damage, linking IER3 to the DNA damage checkpoint: loss of IER3 prevents MCL-1 nuclear accumulation, impairs Chk1 activation and G2 arrest, and causes genomic instability.\",\n      \"evidence\": \"IER3 knockdown/knockout, ATM inhibition, γ-irradiation, nuclear fractionation, Chk1 phosphorylation assay\",\n      \"pmids\": [\"20467439\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How IER3 mediates MCL-1 nuclear import (carrier vs retention mechanism) was not determined\", \"Whether IER3–MCL-1 interaction is direct or requires additional factors in vivo was uncertain\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"IER3 deficiency was shown to promote Th17 differentiation at the expense of Th1 survival through increased mitochondrial ROS, establishing IER3 as a metabolic regulator of T helper cell fate decisions.\",\n      \"evidence\": \"IER3 KO mice in collagen-induced arthritis model, mitochondrial ROS measurement, antioxidant rescue of Th17 skewing\",\n      \"pmids\": [\"22798682\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ROS-mediated Th17 skewing is solely via BATF or involves additional transcription factors was not fully resolved\", \"Cell-intrinsic vs cell-extrinsic contributions in vivo were not separated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"IER3 was identified as a scaffold for a phospho-ERK/DNA-PKcs complex that promotes NHEJ repair in hematopoietic stem cells downstream of TPO, establishing a direct role in DNA repair beyond checkpoint activation.\",\n      \"evidence\": \"Co-IP of ternary IER3/pERK/DNA-PKcs complex, IER3 knockdown and overexpression, NHEJ repair assay in mouse and human HSPCs\",\n      \"pmids\": [\"24184684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether IER3 activates DNA-PKcs kinase activity directly or facilitates its recruitment to DSBs was not resolved\", \"Contribution of IER3-dependent NHEJ to HSC genomic integrity during aging was not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"IER3 was shown to be essential for KrasG12D-driven pancreatic tumorigenesis through PP2A-dependent ERK sustaining, as IER3-deficient mice exhibited delayed PanIN and PDAC formation — providing in vivo genetic evidence that IER3's PP2A-inhibitory function is oncogenically required.\",\n      \"evidence\": \"IER3/KrasG12D compound mutant mice, PP2A phosphatase assay, pERK immunohistochemistry\",\n      \"pmids\": [\"25250570\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether therapeutic PP2A reactivation can substitute for IER3 loss in established tumors was not tested\", \"Contribution of IER3's non-PP2A functions to pancreatic tumorigenesis was not assessed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"MDM2 was identified as the E3 ubiquitin ligase for IER3, with FHL2 acting as a scaffold and K60 as the critical ubiquitination site — defining the proteolytic control mechanism for IER3 protein levels.\",\n      \"evidence\": \"Ubiquitination assay, K60 point mutant, co-IP of MDM2–FHL2–IER3 ternary complex, FHL2/MDM2 siRNA\",\n      \"pmids\": [\"26973248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other E3 ligases contribute to IER3 turnover in specific contexts was not examined\", \"How IER3 ubiquitination is regulated by upstream signals beyond MDM2/FHL2 was not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of IER3's interactions with its multiple partners (B56, ERK, RelA, IF1, MCL-1, DNA-PKcs) remains undetermined, as does how IER3 integrates competing pro-survival and pro-apoptotic outputs in a single cell under physiological conditions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of IER3 or any IER3-containing complex exists\", \"How post-translational modifications dynamically partition IER3 among its functional complexes is unknown\", \"Whether IER3's transmembrane-like domain inserts into membranes or serves as a protein-protein interaction surface is unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 4, 7, 8, 17]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [3, 4, 14, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10, 11, 13]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [9, 11]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [10, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3, 4, 7, 8, 17]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 5, 6, 11, 12]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [13, 14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6, 15]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"complexes\": [\n      \"IER3–pERK–B56-PP2A\",\n      \"IER3–pERK–DNA-PKcs\",\n      \"IER3–MDM2–FHL2\"\n    ],\n    \"partners\": [\n      \"PPP2R5A\",\n      \"PPP2R5B\",\n      \"PPP2R5C\",\n      \"MAPK1\",\n      \"RELA\",\n      \"MCL1\",\n      \"PRKDC\",\n      \"MDM2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}